You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

MAXIPIME Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Maxipime patents expire, and when can generic versions of Maxipime launch?

Maxipime is a drug marketed by Hospira Inc and is included in one NDA.

The generic ingredient in MAXIPIME is cefepime hydrochloride. There are twenty drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the cefepime hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Maxipime

A generic version of MAXIPIME was approved as cefepime hydrochloride by ACS DOBFAR on March 20th, 2008.

  Try a Trial

Drug patent expirations by year for MAXIPIME
Drug Prices for MAXIPIME

See drug prices for MAXIPIME

Recent Clinical Trials for MAXIPIME

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Yasser Esmat MohammedPhase 2/Phase 3
Assiut UniversityPhase 2/Phase 3
Acellena Contract Drug Research and DevelopmentPhase 2

See all MAXIPIME clinical trials

US Patents and Regulatory Information for MAXIPIME

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-002 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-003 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hospira Inc MAXIPIME cefepime hydrochloride INJECTABLE;INJECTION 050679-001 Jan 18, 1996 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.